Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease

Capital Medical University

Status: Completed

Conditions: Meniere Disease

Treatments: Device: taVNS

Study type: Interventional

Funder types: Other

Identifiers

NCT04686695

taVNS-MD-2020

Details and patient eligibility

About

Objective: To evaluate the effect of Transcutaneous auricular vagus nerve stimulation for the patients Meniere disease.

Methods: We accrued 25 patients at Beijing TongRen Hospital. All treatments were self-administered by the patients at home after training at the hospital. Patients completed questionnaires at baseline and after 4 weeks, 8 weeks, 12 weeks.

Tinnitus Handicap Inventory (THI), Dizziness Handicap Inventory (DHI), Pure Tone Audiometry, visual scale of ear stuffiness and SF-36 were performed to evaluate the therapeutic effects.

A difference of P < 0.05 was considered statistically significant.

Enrollment: 25 patients

Sex: All

Ages: 40 to 66 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age >=18 and Age <=70.
2. Clinical diagnosis of meniere disease.

Exclusion criteria

1. History of depression, tumors, thyroid disease, diabetes, cardiac diseases.
2. History of Otorhinolaryngology surgery.
3. Pregnant or lactating women.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

25 participants in 1 patient group

Transcutaneous Auricular Vagus Nerve Stimulation

Experimental group

Treatment:

Device: taVNS